Tag Archives: Rochelle Walensky

A bargain too! Analysis shows early HIV treatment provides good economic value, along with health and transmission prevention

By on .

The landmark HPTN 052 study, which proved in 2011 that treating HIV also prevents transmission of the virus, continues to be the gift that keeps on giving, with data from the multi-site trial now showing that early treatment is cost-effective as well, results of a just-released analysis reported in the New England Journal of Medicine […]

Blueprint: Use proven methods, research, determination to reach end of epidemic

By on .

Dr. Rochelle Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. She is a member of the Office of AIDS Research Advisory Council at the National Institutes of Health and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.  Dr. Walensky has […]

Scale up of HIV Testing is Vital

By on .

In this video interview, Dr. Rochelle Walensky, an associate professor of medicine at Harvard Medical School and an expert in epidemiology and outcomes research, discusses the need to scale up HIV testing and link those who test positive to appropriate care. She also talks about a new avenue to reach men who may be infected […]